Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.

Antimicrobial agents and chemotherapy - 1 Jan 2016

Sanglard Dominique, Coste Alix T

Abstract excerpt

Isavuconazole is a novel, broad-spectrum, antifungal azole. In order to evaluate its interactions with known azole resistance mechanisms, isavuconazole susceptibility among different yeast models and clinical isolates expressing characterized azole resistance mechanisms was tested and compared to those of fluconazole, itraconazole, posaconazole, and voriconazole. Saccharomyces cerevisiae expressing the Candida...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Candida glabrata
Share to Candidiasis
Share to Drug Resistance, Fungal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluconazole

Share to Itraconazole

Share to Nitriles

Share to Triazoles

Share to Voriconazole

Source

Open in PubMed Open full text

Identifiers

PMID: 26482310
DOI: 10.1128/AAC.02157-15
PMCID: PMC4704203

Genes

CDR2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.PMID 26482310Read ↗

Mechanisms of azole resistance among clinical isolates of Candida glabrata in PolandSemantic proximity Read ↗

Evaluation of the in vitro activity of isavuconazole and comparator voriconazole against 2635 contemporary clinical Candida and Aspergillus isolatesSemantic proximity Read ↗

An update on antifungal targets and mechanisms of resistance in Candida albicans.Semantic proximity Read ↗

Pathogenicity and drug resistance in Candida albicans and other yeast speciesSemantic proximity Read ↗

Multiple resistance mechanisms to azole antifungals in yeast clinical isolatesSemantic proximity Read ↗

Azole Susceptibility Profiles of More than 9,000 Clinical Yeast Isolates Belonging to 40 Common and Rare SpeciesSemantic proximity Read ↗

Medically Important Fungi Respond to Azole Drugs: An UpdateSemantic proximity Read ↗

Molecular mechanism of azoles resistant Candida albicans in a patient with chronic mucocutaneous candidiasis.Semantic proximity Read ↗

Mechanisms of azole antifungal resistance in clinical isolates of Candida tropicalisSemantic proximity Read ↗

Resistance mechanisms in clinical isolates of Candida albicans.Semantic proximity Read ↗

Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients.Semantic proximity Read ↗

Azole Resistance in Candida albicans Isolates from Oropharyngeal Candidiasis is Associated with ERG11 Mutation and Efflux OverexpressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.